Deutsche Bank’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-200
| Closed | -$1K | – | 4361 |
|
|
2020
Q2 | $1K | Sell |
200
-7,659
| -97% | -$38.3K | ﹤0.01% | 4131 |
|
|
2020
Q1 | $30K | Sell |
7,859
-86,417
| -92% | -$330K | ﹤0.01% | 3687 |
|
|
2019
Q4 | $568K | Buy |
94,276
+87,518
| +1,295% | +$527K | ﹤0.01% | 2646 |
|
|
2019
Q3 | $49K | Sell |
6,758
-9,821
| -59% | -$71.2K | ﹤0.01% | 3835 |
|
|
2019
Q2 | $223K | Buy |
+16,579
| New | +$223K | ﹤0.01% | 3679 |
|
|
2019
Q1 | – | Sell |
-279,500
| Closed | -$830K | – | 4911 |
|
|
2018
Q4 | $830K | Buy |
279,500
+277,895
| +17,314% | +$825K | ﹤0.01% | 2988 |
|
|
2018
Q3 | $13K | Sell |
1,605
-3,589
| -69% | -$29.1K | ﹤0.01% | 4638 |
|
|
2018
Q2 | $51K | Sell |
5,194
-13,689
| -72% | -$134K | ﹤0.01% | 4523 |
|
|
2018
Q1 | $163K | Sell |
18,883
-8,370
| -31% | -$72.3K | ﹤0.01% | 4153 |
|
|
2017
Q4 | $340K | Sell |
27,253
-44,638
| -62% | -$557K | ﹤0.01% | 3672 |
|
|
2017
Q3 | $600K | Sell |
71,891
-151,317
| -68% | -$1.26M | ﹤0.01% | 3263 |
|
|
2017
Q2 | $3.79M | Buy |
+223,208
| New | +$3.79M | ﹤0.01% | 2099 |
|
|
2016
Q3 | – | Sell |
-3,943
| Closed | -$27K | – | 4722 |
|
|
2016
Q2 | $27K | Buy |
3,943
+3,441
| +685% | +$23.6K | ﹤0.01% | 4353 |
|
|
2016
Q1 | $4K | Sell |
502
-357
| -42% | -$2.85K | ﹤0.01% | 4609 |
|
|
2015
Q4 | $8K | Sell |
859
-94
| -10% | -$875 | ﹤0.01% | 4521 |
|
|
2015
Q3 | $13K | Buy |
+953
| New | +$13K | ﹤0.01% | 4461 |
|